Compare MGM Resorts International (MGM) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs GeneDx Holdings Corp — how do they compare? MGM Resorts International trades at $40.18 (market cap $10.25B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: MGM Resorts International is far larger — about 4× GeneDx Holdings Corp's market cap, and MGM Resorts International pays a 0.03% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| MGM | WGS | |
|---|---|---|
Market Cap | $10.25B | $2.56B |
Sector | Consumer Cyclical | Technology |
52-Week High | $50.69 | $167.51 |
52-Week Low | $30.72 | $34.51 |
Enterprise Value | $37.55B | $2.60B |
Dividend Yield | 0.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGM Resorts International trades at $40.74, down 1.16% on the day, as the stock faces technical bearish pressure despite strong analyst support. The company reported mixed quarterly earnings with two beats and one miss in recent quarters, while maintaining stable revenue around $17.5 billion. Recent news highlights include BetMGM's football season enhancements and ongoing investigation into Barry Diller's $48.30 per share acquisition offer.
MGM presents a compelling valuation case with a P/S ratio of 0.61 below industry averages, supported by 51% analyst buy ratings and a $51.61 consensus price target offering 27% upside. However, declining profit margins and negative cash flow trends pose fundamental concerns, while the bearish technical outlook suggests near-term pressure. The acquisition investigation adds regulatory uncertainty to the investment thesis.
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
